LSD

LSD — Grokipedia Fact-checked by Grok 1 month ago LSD Ara Eve Leo Sal 1x Lysergic acid diethylamide (LSD, from German Lysergsäurediethylamid) is a semisynthetic hallucinogenic compound of the ergoline class, derived from ergot alkaloids produced by the fungus Claviceps purpurea that infects rye and other grains. [1] [2] First synthesized in 1938 by Albert Hofmann at Sandoz Laboratories in Switzerland as part of efforts to develop circulatory and respiratory stimulants from ergot derivatives, its potent psychoactive effects were discovered in 1943 when Hofmann accidentally ingested a trace amount, leading to the first intentional self-experiment confirming its profound influence on perception and consciousness. [3] [4] LSD exerts its effects primarily through high-affinity agonism at serotonin 5-HT 2A receptors in the brain, resulting in altered sensory processing, intensified emotions, synesthesia, and ego dissolution, with subjective experiences typically lasting 8 to 12 hours following oral doses as low as 20–30 micrograms, though 100–200 micrograms are common for full effects. [3] Pharmacologically well-tolerated, LSD exhibits no significant physical dependence, tolerance develops rapidly with repeated use but dissipates quickly, and its acute toxicity is exceptionally low, with lethal doses estimated at thousands of times therapeutic levels and no recorded fatalities from overdose alone. [3] [5] [6] Early clinical investigations in the 1950s and 1960s demonstrated therapeutic promise, particularly in reducing alcohol dependency and alleviating anxiety in terminal illness, with meta-analyses of randomized trials showing sustained benefits. [7] Subsequent prohibition as a Schedule I substance curtailed research amid cultural backlash, yet contemporary placebo-controlled studies reaffirm LSD's safety profile and efficacy in psychedelic-assisted psychotherapy for mood disorders, underscoring discrepancies between empirical harm assessments—ranking it among the least dangerous recreational substances—and historical regulatory narratives emphasizing psychological risks over physiological data. [7] [4] [8] Chemistry Synthesis Lysergic acid diethylamide (LSD) is semisynthesized from ergot alkaloids, primarily ergotamine or ergocristine extracted from the ergot fungus Claviceps purpurea , which infects rye and other grains. [1] Swiss chemist Albert Hofmann first produced LSD on November 16, 1938, at Sandoz Laboratories by deriving lysergic acid through alkaline hydrolysis of ergotamine tartrate, followed by coupling the activated carboxylic acid group of lysergic acid with diethylamine via amidation to form the diethylamide derivative. [9] This key amidation step typically involves converting lysergic acid to an acid chloride intermediate using reagents like thionyl chloride, rendering the carbonyl highly electrophilic for nucleophilic attack by diethylamine, though alternative coupling agents such as trifluoroacetic anhydride have been explored in later patents for mixed anhydride formation. [10] [11] The process demands anhydrous conditions and inert atmospheres to prevent degradation of the sensitive tetracyclic ergoline core, which is prone to epimerization at the C-8 position, yielding inactive iso-lysergic acid diethylamide as a byproduct requiring chromatographic separation. [12] Yields are low—often below 50%—due to the instability of intermediates and the need for precise stereocontrol to retain the natural (5 R )-configuration essential for activity. [1] Hofmann refined the procedure in 1943, optimizing isolation techniques to obtain purer crystalline LSD tartrate, but the core reaction sequence remains unchanged. [9] Contemporary illicit production inherits these challenges, compounded by regulatory controls on precursors: lysergic acid and ergotamine are classified as DEA Schedule III substances in the United States, with ergotamine subject to quotas and import restrictions, forcing clandestine operators to resort to unregulated sources like fungal fermentations or hydrolysis of unregulated ergot derivatives, which introduce variability and contaminants such as clavine alkaloids. [13] Synthesis requires advanced organic laboratory infrastructure, including fume hoods, distillation apparatus, and high-performance liquid chromatography for purification, as incomplete reactions or impurities (e.g., unreacted diethylamine or solvent residues) can render batches toxic or inactive at microgram doses. [9] Illicit yields suffer further from suboptimal conditions, often resulting in purity levels below 90%, heightening risks of adverse byproducts like lumi-LSD from light exposure during handling. [14] Chemical structure and properties The compound is commonly known as lysergic acid diethylamide, abbreviated LSD from the German Lysergsäurediethylamid. Its systematic IUPAC name is (6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide. An alternative naming convention based on the ergoline structure is 9,10-didehydro-N,N-diethyl-6-methylergoline-8β-carboxamide. Also known as lysergide or d-lysergic acid diethylamide. LSD possesses the molecular formula C 20 H 25 N 3 O and a molar mass of 323.43 g/mol. [15] It is classified as a semi-synthetic ergoline alkaloid, derived from lysergic acid found in ergot fungi such as Claviceps purpurea . The core structure consists of a tetracyclic ergoline skeleton, featuring an indole ring fused to a quinoline-like system with a double bond between carbons 9 and 10, a methyl group on the indole nitrogen, and a carboxamide at position 8 substituted with two ethyl groups to form the diethylamide moiety. [16] This diethylamide substitution differentiates LSD from natural ergot alkaloids like ergotamine and ergocristine, which feature complex peptide chains attached to the lysergic acid core rather than a simple dialkyl amide, altering solubility and biological activity profiles. Ergolines like LSD relate to simpler tryptamines through the shared indole nucleus but are distinguished by the additional fused D-ring and carboxamide, conferring unique rigidity and receptor affinity potential. [17] [18] In pure form, LSD base manifests as colorless, odorless, tasteless prismatic crystals with a melting point of approximately 80–85 °C, though it often decomposes upon heating. [16] The base exhibits low solubility in water (slightly soluble) and neutral organic solvents but dissolves readily in acidic or alkaline solutions, chloroform, and ethanol; for practical use, it is commonly converted to the water-soluble tartrate salt. [16] [17] LSD demonstrates instability to ultraviolet light, undergoing photodegradation to the inactive iso-lysergic acid diethylamide or lumi compounds, as well as sensitivity to elevated temperatures and alkaline pH, requiring storage in amber containers at low temperatures to maintain integrity. [19] [20] Stability and detection LSD exhibits notable chemical instability, primarily due to sensitivity to oxygen, ultraviolet (UV) light, and heat, which accelerate its decomposition into products such as lumi-LSD (a photo-oxidation byproduct). [21] Exposure to chlorine, as in bleach or chlorinated water, further promotes rapid degradation by oxidative cleavage of the indole ring. [22] Under suboptimal conditions like ambient light or air, LSD can lose up to 50% potency within weeks, whereas proper storage—in opaque, airtight containers at low temperatures (e.g., 4°C or below) and low humidity—can preserve over 90% potency for 2–3 years or longer, based on controlled studies of diluted solutions. [19] These factors necessitate careful handling to maintain efficacy in research or therapeutic contexts, as epimerization to inactive iso-LSD also occurs in neutral to basic pH environments. [23] Detection of LSD relies on analytical techniques suited to its low doses (typically 50–200 μg) and structural similarity to ergot alkaloids. High-performance liquid chromatography (HPLC) coupled with mass spectrometry (MS), or gas chromatography-mass spectrometry (GC-MS) following derivatization to enhance volatility, enables quantification in biological fluids or seized materials with limits of detection around 0.1–1 ng/mL in urine. [24] [25] Liquid chromatography-tandem mass spectrometry (LC-MS/MS) offers higher specificity for distinguishing LSD from metabolites like 2-oxo-3-hydroxy-LSD without derivatization. Field screening employs presumptive color tests, such as the Ehrlich reagent, which produces a purple reaction with indole-based compounds like LSD, though confirmatory lab analysis is essential due to potential false positives from other tryptamines. [26] These methods support forensic identification, with UV spectroscopy or immunoassays providing initial triage in high-volume screening. Street LSD samples, often on blotter paper, are generally of high purity due to the drug's extreme potency requiring minimal material, reducing economic incentive for dilution with inert bulking agents common in other illicit substances. However, analyses reveal occasional contaminants or adulterants like caffeine, ergotamine derivatives, or synthetic mimics introduced during clandestine synthesis, potentially exacerbating health risks such as vasoconstriction or neurotoxicity from impurities. [27] Detection of such adulterants via GC-MS or HPLC underscores the need for purity verification, as undeclared additions can amplify adverse reactions beyond LSD's inherent profile, though systematic data on prevalence remains limited compared to opioids or stimulants. [28] Analogues and mimics Lysergamide analogues of LSD feature modifications primarily at the N1 position of the indole ring, such as acetylation or propionylation, which confer prodrug properties by enabling hydrolysis to the active LSD molecule in vivo. [29] ALD-52, or 1-acetyl-LSD, exemplifies this class, undergoing rapid deacetylation to LSD, likely accounting for its pharmacological similarity w